Bertrand Georges

836 total citations
26 papers, 529 citations indexed

About

Bertrand Georges is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Bertrand Georges has authored 26 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Bertrand Georges's work include vaccines and immunoinformatics approaches (8 papers), Immunotherapy and Immune Responses (8 papers) and Influenza Virus Research Studies (5 papers). Bertrand Georges is often cited by papers focused on vaccines and immunoinformatics approaches (8 papers), Immunotherapy and Immune Responses (8 papers) and Influenza Virus Research Studies (5 papers). Bertrand Georges collaborates with scholars based in France, United States and United Kingdom. Bertrand Georges's co-authors include James N. Francis, Katie Anderson, Florence Castelli, Bernard Maillère, John S. Tregoning, Alethea Cope, Juergen Hammer, Andre Ménèz, Sandra Pouvelle‐Moratille and Hélène Gras‐Masse and has published in prestigious journals such as Circulation, The Journal of Immunology and Journal of Virology.

In The Last Decade

Bertrand Georges

25 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bertrand Georges France	12	259	240	172	110	48	26	529
Eiji Watari Japan	14	351 1.4×	161 0.7×	100 0.6×	76 0.7×	39 0.8×	37	554
Stefanía P. Bjarnarson Iceland	12	309 1.2×	255 1.1×	132 0.8×	86 0.8×	164 3.4×	21	652
Wendy L. Trigona United States	11	497 1.9×	227 0.9×	187 1.1×	96 0.9×	48 1.0×	16	831
Susan Smyk‐Pearson United States	8	733 2.8×	336 1.4×	93 0.5×	132 1.2×	46 1.0×	8	994
Lisa Hyland United Kingdom	10	588 2.3×	285 1.2×	63 0.4×	108 1.0×	13 0.3×	12	789
Fumin Liu China	15	127 0.5×	269 1.1×	119 0.7×	241 2.2×	38 0.8×	60	610
Canh P. Quan France	11	213 0.8×	70 0.3×	97 0.6×	62 0.6×	116 2.4×	21	419
M W Steward United Kingdom	13	228 0.9×	176 0.7×	155 0.9×	50 0.5×	162 3.4×	17	512
Miranda S. Moore United States	12	120 0.5×	146 0.6×	700 4.1×	92 0.8×	19 0.4×	41	1.0k
L Dianda United Kingdom	7	401 1.5×	107 0.4×	192 1.1×	120 1.1×	80 1.7×	7	690

Countries citing papers authored by Bertrand Georges

Since Specialization

Citations

This map shows the geographic impact of Bertrand Georges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Georges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Georges more than expected).

Fields of papers citing papers by Bertrand Georges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Georges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Georges. The network helps show where Bertrand Georges may publish in the future.

Co-authorship network of co-authors of Bertrand Georges

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Georges. A scholar is included among the top collaborators of Bertrand Georges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Georges. Bertrand Georges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Browne, Sarah, John J. Suschak, Shaheen Tomah, et al.. (2025). Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial. JHEP Reports. 7(11). 101483–101483.

Harrison, Stephen A., Shaheen Tomah, John J. Suschak, et al.. (2023). Pemvidutide, a glp-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial. Journal of Hepatology. 78. S54–S55. 4 indexed citations

Hassert, Mariah, Katherine E. Schwetye, Jianfeng Zhang, et al.. (2023). The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model. Frontiers in Immunology. 14. 1188392–1188392. 2 indexed citations

Plutzky, Jorge, Cristina Alonso, John J. Suschak, et al.. (2022). Abstract 13440: Effect of Pemvidutide (ALT-801), a Novel GLP-1/Glucagon Dual Receptor Agonist, on Pathogenic Lipid Mediators. Circulation. 146(Suppl_1). 1 indexed citations

Schultz, Michael D., John J. Suschak, Davide Botta, et al.. (2022). A single intranasal administration of AdCOVID protects against SARS-CoV-2 infection in the upper and lower respiratory tracts. Human Vaccines & Immunotherapeutics. 18(6). 11 indexed citations

Lim, Young-Suk, David Mutimer, Jeong Heo, et al.. (2019). PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection. Journal of Hepatology. 70(1). e50–e51. 16 indexed citations

Francis, James N., et al.. (2017). Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre. Frontiers in Microbiology. 8. 900–900. 86 indexed citations

Francis, James N., et al.. (2015). Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system. Vaccine. 33(8). 1071–1076. 4 indexed citations

Watson, Jeannette M., James N. Francis, J. Makin, et al.. (2015). Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans. Virology Journal. 12(1). 13–13. 20 indexed citations

10.

Francis, James N., Campbell Bunce, Claire Horlock, et al.. (2014). A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety. Vaccine. 33(2). 396–402. 46 indexed citations

11.

Depil, Stéphane, Olivier Moralès, Florence Castelli, et al.. (2007). Determination of a HLA II Promiscuous Peptide Cocktail as Potential Vaccine Against EBV Latency II Malignancies. Journal of Immunotherapy. 30(2). 215–226. 23 indexed citations

12.

Castelli, Florence, Sandra Pouvelle‐Moratille, Hassane M. Zarour, et al.. (2007). Differential capacity of T cell priming in naive donors of promiscuous CD4⁺ T cell epitopes of HCV NS3 and Core proteins. European Journal of Immunology. 37(6). 1513–1523. 23 indexed citations

13.

Depil, Stéphane, Gerhild Angyalosi, Olivier Moralès, et al.. (2005). Peptide-binding assays and HLA II transgenic Aβ° mice are consistent and complementary tools for identifying HLA II-restricted peptides. Vaccine. 24(13). 2225–2229. 7 indexed citations

14.

Auriault, Claude, et al.. (2002). Evidences of conformational changes in class II Major Histocompatibility Complex molecules that affect the immunogenicity. Molecular Immunology. 38(9). 661–667. 3 indexed citations

15.

Castelli, Florence, Cécile Buhot, Alain Sanson, et al.. (2002). HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity. The Journal of Immunology. 169(12). 6928–6934. 97 indexed citations

16.

Georges, Bertrand, et al.. (2000). Structural diversity of human class II histocompatibility molecules induced by peptide ligands. FEBS Letters. 481(3). 249–254. 4 indexed citations

17.

Gras‐Masse, Hélène, Bertrand Georges, Jérôme Estaquier, et al.. (1999). Convergent peptide libraries, or mixotopes, to elicit or to identify specific immune responses. Current Opinion in Immunology. 11(2). 223–228. 5 indexed citations

18.

Georges, Bertrand, Marc Bossus, Jérôme Estaquier, et al.. (1997). Analysis of the immune response elicited by a Multiple Antigen Peptide (MAP) composed of two distinct protective antigens derived from the parasite Schistosoma mansoni. Parasite Immunology. 19(1). 1–12. 20 indexed citations

19.

Salmon, Valérie, Dominique Legrand, Bertrand Georges, et al.. (1997). Characterization of Human Lactoferrin Produced in the Baculovirus Expression System. Protein Expression and Purification. 9(2). 203–210. 46 indexed citations

20.

Estaquier, Jérôme, et al.. (1996). A Combinatorial Peptide Library Around Variation of the Human Immunode ficiency Virus (HIV‐1) V3 Domain Leads to Distinct T Helper Cell Responses. Journal of Peptide Science. 2(3). 165–175. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact